Kestra Medical Technologies (KMTS) Accumulated Depreciation & Amortization (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Accumulated Depreciation & Amortization data on file, last reported at $29.5 million in Q1 2026.

• Quarterly Accumulated Depreciation & Amortization rose 78.86% year-over-year to $29.5 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $29.5 million (up 78.86% YoY) and the FY2025 annual result came in at $24.0 million, up 36.53% from the prior year.
• Accumulated Depreciation & Amortization climbed to $29.5 million in Q1 2026 per KMTS's latest filing, from $27.8 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $29.5 million in Q1 2026 and bottomed at $16.5 million in Q1 2025.
• The 3-year median for Accumulated Depreciation & Amortization is $24.8 million (2025), against an average of $23.5 million.
• The widest annual swing landed in 2025, when Accumulated Depreciation & Amortization jumped 36.53%; it then soared 78.86% in 2026.
• Tracing KMTS's Accumulated Depreciation & Amortization over 3 years: stood at $17.5 million in 2024, then jumped by 58.24% to $27.8 million in 2025, then advanced by 6.16% to $29.5 million in 2026.
• Per Business Quant, the three latest KMTS Accumulated Depreciation & Amortization figures stand at $29.5 million (Q1 2026), $27.8 million (Q4 2025), and $25.7 million (Q3 2025).

Peer Comparison